Pasteur Institute of Lille, U1019-UMR 8204-CIIL- Center for Infection and Immunity of Lille, University of Lille, CNRS, INSERM, CHU Lille, Lille, France.
Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Cell Microbiol. 2018 Jan;20(1). doi: 10.1111/cmi.12804. Epub 2017 Nov 17.
The hepatitis E virus (HEV) genome is a single-stranded, positive-sense RNA that encodes three proteins including the ORF1 replicase. Mechanisms of HEV replication in host cells are unclear, and only a few cellular factors involved in this step have been identified so far. Here, we used brefeldin A (BFA) that blocks the activity of the cellular Arf guanine nucleotide exchange factors GBF1, BIG1, and BIG2, which play a major role in reshuffling of cellular membranes. We showed that BFA inhibits HEV replication in a dose-dependent manner. The use of siRNA and Golgicide A identified GBF1 as a host factor critically involved in HEV replication. Experiments using cells expressing a mutation in the catalytic domain of GBF1 and overexpression of wild type GBF1 or a BFA-resistant GBF1 mutant rescuing HEV replication in BFA-treated cells, confirmed that GBF1 is the only BFA-sensitive factor required for HEV replication. We demonstrated that GBF1 is likely required for the activity of HEV replication complexes. However, GBF1 does not colocalise with the ORF1 protein, and its subcellular distribution is unmodified upon infection or overexpression of viral proteins, indicating that GBF1 is likely not recruited to replication sites. Together, our results suggest that HEV replication involves GBF1-regulated mechanisms.
戊型肝炎病毒 (HEV) 基因组是一条单链、正链 RNA,编码包括 ORF1 复制酶在内的三种蛋白。HEV 在宿主细胞中的复制机制尚不清楚,迄今为止,仅鉴定出少数参与这一步骤的细胞因子。在这里,我们使用布雷菲德菌素 A (BFA) 阻断细胞 Arf 鸟嘌呤核苷酸交换因子 GBF1、BIG1 和 BIG2 的活性,这些因子在细胞内膜的重排中起主要作用。我们表明 BFA 以剂量依赖的方式抑制 HEV 复制。使用 siRNA 和 GolgiCide A 鉴定出 GBF1 是参与 HEV 复制的关键宿主因子。使用表达 GBF1 催化结构域突变的细胞以及过表达野生型 GBF1 或挽救 BFA 处理细胞中 HEV 复制的 BFA 抗性 GBF1 突变体的实验,证实 GBF1 是 HEV 复制所必需的唯一 BFA 敏感因子。我们表明 GBF1 可能是 HEV 复制复合物活性所必需的。然而,GBF1 与 ORF1 蛋白不共定位,并且其亚细胞分布在感染或过表达病毒蛋白时未改变,表明 GBF1 不太可能被招募到复制部位。总之,我们的结果表明,HEV 复制涉及 GBF1 调节的机制。